{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:07:26Z","timestamp":1770822446402,"version":"3.50.1"},"reference-count":27,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1991,3]]},"abstract":"<jats:p>S-phase fraction, an index of cellular proliferation, and DNA ploidy were measured by DNA flow cytometry in a retrospective study of lymph node biopsy specimens from 83 cases (before treatment) of follicular non-Hodgkin's lymphoma, Working Formulation categories B and C. The correlations between these measures and survival, clinical stage, symptoms and histopathological factors were investigated. Aneuploidy was rare (n = 16) and had no effect on length of survival or transformation to high grade lymphoma. The overall mean S-phase fraction was 3.6%; for the whole series increasing S-phase fraction was associated with decreased survival. A high S-phase fraction (more than 5%) in initial biopsy specimens was also associated with an increased risk of subsequent high grade transformation at relapse. There was no difference between the survival or proliferative activity of tumours composed of mainly small cleaved cells compared with those composed of mixed small and large cells. There was no difference in survival or proliferative activity between tumours showing a pure follicular growth pattern and those with a mixed follicular and diffuse growth pattern. Multifactorial analysis showed that an S-phase fraction of more than 5% and B symptoms were the most important factors determining survival in these follicular non-Hodgkin's lymphomas.<\/jats:p>","DOI":"10.1136\/jcp.44.3.215","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"215-218","source":"Crossref","is-referenced-by-count":30,"title":["DNA flow cytometry of follicular non-Hodgkin's lymphoma."],"prefix":"10.1136","volume":"44","author":[{"given":"J C","family":"Macartney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R S","family":"Camplejohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Hollowood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Timothy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1991,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0014-2964(70)90045-9","article-title":"The pattem of cell growth in reticulum cell sarcoma and lymphosarcoma","volume":"6","author":"Peckham, M.; Cooper, E.H.","year":"1970","unstructured":"Peckham M, Cooper EH. The pattem of cell growth in reticulum cell sarcoma and lymphosarcoma. Eur J Cancer 1970;6:453-63.","journal-title":"Eur J Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0277-5379(90)90095-B","article-title":"DNA flow cytometry of non-Hodgkin's lymphoma","volume":"26","author":"Macartney, J.C.; Camplejohn, R.S.","year":"1990","unstructured":"Macartney JC, Camplejohn RS. DNA flow cytometry of non-Hodgkin's lymphoma. Eur J Clin Oncol 1990;26: 635-7.","journal-title":"Eur J Clin Oncol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1986.4.10.1470","article-title":"Follicular lymphoma: prognostic factors for response and survival","volume":"4","author":"Gallagher, C.J.; Gregory, W.M.; Jones, A.E.","year":"1986","unstructured":"Gallagher CJ, Gregory WM, Jones AE, et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 1986;4:1470-80.","journal-title":"J Clin Oncol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/jcp.41.8.866","article-title":"Prognostic indicators in centroblastic-centrocytic lymphoma","volume":"41","author":"Griffin, N.R.; Howard, M.R.; Quirke, P.","year":"1988","unstructured":"Griffin NR, Howard MR, Quirke P, et al. Prognostic indicators in centroblastic-centrocytic lymphoma. J Clin Pathol 1988;41:866-70.","journal-title":"J Clin Pathol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jcp.39.5.542","article-title":"Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas","volume":"39","author":"Macartney, J.C.; Camplejohn, R.S.; Alder, J.","year":"1986","unstructured":"Macartney JC, Camplejohn RS, Alder J, et al. Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas. J Clin Pathol 1986;39:542-6.","journal-title":"J Clin Pathol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for clinical usage","volume":"49","year":"1982","unstructured":"The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 1982;49:2112-35.","journal-title":"Cancer"},{"key":"ref_7","article-title":"Malignant lymphomas other than Hodgkin's disease","author":"Lennert, K.","year":"1978","unstructured":"Lennert K. Malignant lymphomas other than Hodgkin's disease. Berlin: Springer-Verlag, 1978."},{"key":"ref_8","first-page":"44","article-title":"Sclerosis in non-Hodgkin's lymphomas","volume":"II):","author":"Bennett, M.H.","year":"1975","unstructured":"Bennett MH. Sclerosis in non-Hodgkin's lymphomas. Br J Cancer 1975;31(Suppl II):44-52.","journal-title":"Br J Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1177\/31.11.6619538","article-title":"Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry","volume":"31","author":"Hedley, D.W.; Friedlander, M.L.; Taylor, I.W.","year":"1983","unstructured":"Hedley DW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.","journal-title":"J Histochem Cytochem"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jcp.38.10.1096","article-title":"Comparison of DNA flow cytometry from fresh and paraffin embedded samples of non-Hodgkin's lymphoma","volume":"38","author":"Camplejohn, R.S.; Macartney, J.C.","year":"1985","unstructured":"Camplejohn RS, Macartney JC. Comparison of DNA flow cytometry from fresh and paraffin embedded samples of non-Hodgkin's lymphoma. J Clin Pathol 1985;38:1096-9.","journal-title":"J Clin Pathol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/cyto.990100408","article-title":"S-phase fractions in lymphoid tissue: fresh versus paraffin-embedded tissue and DAPI versus PI staining","volume":"10","author":"Camplejohn, R.S.; Macartney, J.C.","year":"1989","unstructured":"Camplejohn RS, Macartney JC. S-phase fractions in lymphoid tissue: fresh versus paraffin-embedded tissue and DAPI versus PI staining. Cytometry 1989;10:410-16.","journal-title":"Cytometry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02339807","article-title":"Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle","volume":"12","author":"Baisch, H.; Gohde, W.; Linden, W.A.","year":"1975","unstructured":"Baisch H, Gohde W, Linden WA. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys 1975;12:31-9.","journal-title":"Radiat Environ Biophys"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient","volume":"35","author":"Peto, R.; Pike, M.C.; Armitage, P.","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.","journal-title":"II. Analysis and examples. Br J Cancer"},{"key":"ref_14","first-page":"436","article-title":"Statistical methods in medical research","author":"Armitage, P.; Berry, G.","year":"1987","unstructured":"Armitage P, Berry G. Statistical methods in medical research. 2nd edition. Oxford: Blackwell, 1987:436-7.","edition":"2nd edition"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/1097-0142(197912)44:6<2236::AID-CNCR2820440635>3.0.CO;2-E","article-title":"Malignant lymphomas of follicular center origin in man III. Prognostic features","volume":"44","author":"Stein, R.S.; Cousar, J.; Flexner, J.M.","year":"1979","unstructured":"Stein RS, Cousar J, Flexner JM, et al. Malignant lymphomas of follicular center origin in man III. Prognostic features. Cancer 1979;44:2236-43.","journal-title":"Cancer"},{"key":"ref_16","first-page":"269","article-title":"Clinical and prognostic relevance of the Kiel Lymphoma Study Group","volume":"2","author":"Brittinger, G.; Bartels, H.; Common, H.","year":"1984","unstructured":"Brittinger G, Bartels H, Common H, et al. Clinical and prognostic relevance of the Kiel Lymphoma Study Group. Hematol Oncol 1984;2:269-306."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0360-3016(84)90028-2","article-title":"Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience","volume":"10","author":"Gospodarowicz, M.K.; Bush, R.S.; Brown, T.C.","year":"1984","unstructured":"Gospodarowicz MK, Bush RS, Brown TC, et al. Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 1984;10:489-97.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref_18","first-page":"261","article-title":"Nodular mixed lymphocytic-histiocytic lymphoma (NM)","volume":"45","author":"Ezdinli, E.Z.; Costello, W.G.; Icli, F.","year":"1980","unstructured":"Ezdinli EZ, Costello WG, Icli F, et al. Nodular mixed lymphocytic-histiocytic lymphoma (NM). Response and survival. Cancer 1980;45:261-7.","journal-title":"Response and survival. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/1097-0142(19831215)52:12<2300::AID-CNCR2820521224>3.0.CO;2-Y","article-title":"Analysis of nonHodgkin's lymphomas with nodular and favourable histologies, stage I and II","volume":"52","author":"Paryani, S.B.; Hoppe, R.T.; Cox, R.S.","year":"1983","unstructured":"Paryani SB, Hoppe RT, Cox RS, et al. Analysis of nonHodgkin's lymphomas with nodular and favourable histologies, stage I and II. Cancer 1983;52:2300-7.","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0046-8177(87)80035-7","article-title":"Mitotic counts in follicular lymphomas","volume":"18","author":"Ellison, D.J.; Nathwani, B.N.; Metter, G.E.","year":"1987","unstructured":"Ellison DJ, Nathwani BN, Metter GE, et al. Mitotic counts in follicular lymphomas. Hum Pathol 1987;18:502-5.","journal-title":"Hum Pathol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bjc.1987.41","article-title":"Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis","volume":"55","author":"Akerman, M.; Brandt, L.; Johnson, A.","year":"1987","unstructured":"Akerman M, Brandt L, Johnson A, et al. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis. Br J Cancer 1987;55:219-23.","journal-title":"Br J Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2559.1989.tb02204.x","article-title":"A retrospective study of follicular lymphoma","volume":"14","author":"West, K.P.; Potter, L.J.; Henderson, S.D.","year":"1989","unstructured":"West KP, Potter LJ, Henderson SD, et al. A retrospective study of follicular lymphoma. Histopathol 1989;14: 629-36.","journal-title":"Histopathol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/1097-0142(19860915)58:6<1295::AID-CNCR2820580620>3.0.CO;2-H","article-title":"Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification","volume":"58","author":"Christensson, B.; Tribukait, B.; Linder, I.-L.","year":"1986","unstructured":"Christensson B, Tribukait B, Linder I-L, et al. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer 1986;58:1295-304.","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.1711540305","article-title":"The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma","volume":"154","author":"Hall, P.A.; Richards, M.A.; Gregory, W.E.M.","year":"1988","unstructured":"Hall PA, Richards MA, Gregory WEM, et al. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988;154:223-36.","journal-title":"J Pathol"},{"key":"ref_25","first-page":"27","article-title":"Flow cytometric DNA analysis","volume":"157","author":"Lehtinen, T.; Aine, R.; Lehtinen, M.","year":"1989","unstructured":"Lehtinen T, Aine R, Lehtinen M, et al. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin's lymphomas. J Pathol 1989; 157:27-36.","journal-title":"J Pathol; favourable or unfavourable non-Hodgkin's lymphomas"},{"key":"ref_26","first-page":"1","article-title":"Labelling index as a prognostic marker in non-Hodgkin's lymphoma","volume":"66","author":"Costa, A.; Bonadonna, G.; Villa, E.","year":"1981","unstructured":"Costa A, Bonadonna G, Villa E, et al. Labelling index as a prognostic marker in non-Hodgkin's lymphoma. JNCI 1981;66:1-5.","journal-title":"JNCI"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900080102","article-title":"Prognostic significance of flow cytometry studies in B-cell non-Hodgkin's lymphomas","volume":"8","author":"Rehn, S.; Glimelius, B.; Strang, P.","year":"1990","unstructured":"Rehn S, Glimelius B, Strang P, et al. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin's lymphomas. Hematol Oncol 1990;8:1-12. Eponyms in pathology...","journal-title":"Hematol Oncol"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.44.3.215","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:17:41Z","timestamp":1765599461000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.44.3.215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1991,3,1]]},"published-print":{"date-parts":[[1991,3]]}},"alternative-id":["10.1136\/jcp.44.3.215"],"URL":"https:\/\/doi.org\/10.1136\/jcp.44.3.215","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,3]]}}}